Elena Cacho-Asenjo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elena Cacho-Asenjo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Martinez-Simon
Department of Anesthesia Perioperative Medicine and Critical Care, Clínica Universidad de Navarra Pamplona Spain
6 shared publications Cristina Honorato-Cia
3 shared publications- Cristina Honorato-Cia
Department of Anesthesia Perioperative Medicine and Critical Care, Clínica Universidad de Navarra Pamplona Spain
2 shared publications - Jorge Guridi
Servicio de Neurocirugía, Clínica Universidad de Navarra, Pamplona, Spain
2 shared publications - Alfonso L. Sabater
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
1 shared publication Alfredo Panadero
1 shared publication
Latest Publications
- Open Access
- 18 September 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 95 (2) , 1123-1134
Optimization of pseudo‐continuous arterial spin labeling for brain perfusion imaging in the intraoperative setting
Purpose: Pseudo‐continuous arterial spin labeling (PCASL) efficiency during intraoperative MRI is degraded due to large field inhomogeneities observed in some patients and lower arterial blood velocities induced by anesthesia. The purpose of this work was to maximize labeling efficiency during intraoperative MRI by optimizing PCASL parameters at 3 T. Methods: Effects of PCASL labeling pulse interval and gradient parameters on labeling efficiency were first investigated by numerical simulations based on Bloch equations. PCASL parameters were modified accordingly, considering hardware constraints, and evaluated experimentally. An experiment in healthy volunteers compared three labeling pulse intervals. In intraoperative brain tumor patients, different configurations were tested in two experiments: different labeling pulse intervals in patient experiment 1, and different labeling pulse interval and gradient average () in experiment 2. Results: Numerical simulations showed that shortening the labeling pulse interval improved robustness of PCASL to off‐resonance effects and that raising the increased labeling efficiency for lower blood velocity profiles. In healthy volunteers for large off‐resonance, perfusion signal obtained with the labeling pulse interval of 600 μs was significantly higher than the one obtained with 1000 μs and 1400 μs ( p‐value < 0.001). In patients, a short labeling pulse interval of 600 μs and of 0.9 mT/m improved the quality of perfusion maps and significantly increased quantified cerebral blood flow values ( p‐value = 0.0078). Conclusion: Shortening the labeling pulse interval and increasing the gradient average improves PCASL efficiency in the intraoperative setting.
- 18 September 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 95 (2) , 1123-1134
Open AccessOptimization of pseudo‐continuous arterial spin labeling for brain perfusion imaging in the intraoperative setting
Purpose: Pseudo‐continuous arterial spin labeling (PCASL) efficiency during intraoperative MRI is degraded due to large field inhomogeneities observed in some patients and lower arterial blood velocities induced by anesthesia. The purpose of this work was to maximize labeling efficiency during intraoperative MRI by optimizing PCASL parameters at 3 T. Methods: Effects of PCASL labeling pulse interval and gradient parameters on labeling efficiency were first investigated by numerical simulations based on Bloch equations. PCASL parameters were modified accordingly, considering hardware constraints, and evaluated experimentally. An experiment in healthy volunteers compared three labeling pulse intervals. In intraoperative brain tumor patients, different configurations were tested in two experiments: different labeling pulse intervals in patient experiment 1, and different labeling pulse interval and gradient average () in experiment 2. Results: Numerical simulations showed that shortening the labeling pulse interval improved robustness of PCASL to off‐resonance effects and that raising the increased labeling efficiency for lower blood velocity profiles. In healthy volunteers for large off‐resonance, perfusion signal obtained with the labeling pulse interval of 600 μs was significantly higher than the one obtained with 1000 μs and 1400 μs ( p‐value < 0.001). In patients, a short labeling pulse interval of 600 μs and of 0.9 mT/m improved the quality of perfusion maps and significantly increased quantified cerebral blood flow values ( p‐value = 0.0078). Conclusion: Shortening the labeling pulse interval and increasing the gradient average improves PCASL efficiency in the intraoperative setting.
- Open Access
- 1 February 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (3) , 298
Long COVID Research, 2020–2024: A PubMed-Based Bibliometric Analysis
Long COVID is a SARS-CoV-2 infection-associated chronic condition with great potential to impact health and socioeconomic outcomes. The research efforts to face the challenges related to long COVID have resulted in a substantial amount of publications, which warrants the need for bibliometric profiling. This is a large-scale PubMed-based bibliometric analysis of more than 390,000 COVID-19 publications. The overall aim was to update the profile of long COVID publications in comparison with the rest of the COVID-19 scientific literature through December 2024. The estimated proportion of long COVID publications was relatively low (2.3% of all COVID-19 publications), although the cumulative frequency (n = 8928) continues to pose a challenge for proper information management. Currently, “treatment” and “mechanism” appear to be the most predominant research topics in the long COVID literature. Interestingly, this evaluation revealed a distinctive profile of the long COVID literature, with a clear preponderance of “case report” and “mechanism” research topics when compared with other COVID-19 publications. This evaluation also identified and ranked the most prolific scientific journals in the production of long COVID-related publications. This study may improve the visibility of long COVID research and contribute to the management of the growing scientific knowledge on long COVID.
- 1 February 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (3) , 298
Open AccessLong COVID Research, 2020–2024: A PubMed-Based Bibliometric Analysis
Long COVID is a SARS-CoV-2 infection-associated chronic condition with great potential to impact health and socioeconomic outcomes. The research efforts to face the challenges related to long COVID have resulted in a substantial amount of publications, which warrants the need for bibliometric profiling. This is a large-scale PubMed-based bibliometric analysis of more than 390,000 COVID-19 publications. The overall aim was to update the profile of long COVID publications in comparison with the rest of the COVID-19 scientific literature through December 2024. The estimated proportion of long COVID publications was relatively low (2.3% of all COVID-19 publications), although the cumulative frequency (n = 8928) continues to pose a challenge for proper information management. Currently, “treatment” and “mechanism” appear to be the most predominant research topics in the long COVID literature. Interestingly, this evaluation revealed a distinctive profile of the long COVID literature, with a clear preponderance of “case report” and “mechanism” research topics when compared with other COVID-19 publications. This evaluation also identified and ranked the most prolific scientific journals in the production of long COVID-related publications. This study may improve the visibility of long COVID research and contribute to the management of the growing scientific knowledge on long COVID.
- 1 June 2017
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 126 (6) , 1033-1042
Effect of Dexmedetomidine and Propofol on Basal Ganglia Activity in Parkinson Disease
Background: Deep brain stimulation electrodes can record oscillatory activity from deep brain structures, known as local field potentials. The authors’ objective was to evaluate and quantify the effects of dexmedetomidine (0.2 μg·kg-1·h-1) on local field potentials in patients with Parkinson disease undergoing deep brain stimulation surgery compared with control recording (primary outcome), as well as the effect of propofol at different estimated peak effect site concentrations (0.5, 1.0, 1.5, 2.0, and 2.5 μg/ml) from control recording. Methods: A nonrandomized, nonblinded controlled clinical trial was carried out to assess the change in local field potentials activity over time in 10 patients with Parkinson disease who underwent deep brain stimulation placement surgery (18 subthalamic nuclei). The relationship was assessed between the activity in nuclei in the same patient at a given time and repeated measures from the same nucleus over time. Results: No significant difference was observed between the relative beta power of local field potentials in dexmedetomidine and control recordings (−7.7; 95% CI, −18.9 to 7.6). By contrast, there was a significant decline of 12.7% (95% CI, −21.3 to −4.7) in the relative beta power of the local field potentials for each increment in the estimated peak propofol concentrations at the effect site relative to the control recordings. Conclusions: Dexmedetomidine (0.2 μg·kg-1·h-1) did not show effect on local field potentials compared with control recording. A significant deep brain activity decline from control recording was observed with incremental doses of propofol.
- 1 June 2017
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 126 (6) , 1033-1042
Effect of Dexmedetomidine and Propofol on Basal Ganglia Activity in Parkinson Disease
Background: Deep brain stimulation electrodes can record oscillatory activity from deep brain structures, known as local field potentials. The authors’ objective was to evaluate and quantify the effects of dexmedetomidine (0.2 μg·kg-1·h-1) on local field potentials in patients with Parkinson disease undergoing deep brain stimulation surgery compared with control recording (primary outcome), as well as the effect of propofol at different estimated peak effect site concentrations (0.5, 1.0, 1.5, 2.0, and 2.5 μg/ml) from control recording. Methods: A nonrandomized, nonblinded controlled clinical trial was carried out to assess the change in local field potentials activity over time in 10 patients with Parkinson disease who underwent deep brain stimulation placement surgery (18 subthalamic nuclei). The relationship was assessed between the activity in nuclei in the same patient at a given time and repeated measures from the same nucleus over time. Results: No significant difference was observed between the relative beta power of local field potentials in dexmedetomidine and control recordings (−7.7; 95% CI, −18.9 to 7.6). By contrast, there was a significant decline of 12.7% (95% CI, −21.3 to −4.7) in the relative beta power of the local field potentials for each increment in the estimated peak propofol concentrations at the effect site relative to the control recordings. Conclusions: Dexmedetomidine (0.2 μg·kg-1·h-1) did not show effect on local field potentials compared with control recording. A significant deep brain activity decline from control recording was observed with incremental doses of propofol.
- 16 December 2015
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 93 (6) , 393-399
Factors Associated with Tremor Changes during Sedation with Dexmedetomidine in Parkinson's Disease Surgery
Introduction: Dexmedetomidine is an α2-agonist recently proposed as a potentially ideal drug for sedation during the surgical treatment of Parkinsonʼs disease (PD). This report documents the incidence of changes in motor symptoms (especially tremor) in PD patients sedated with dexmedetomidine for deep brain stimulation or ablation procedures. Methods: We reviewed a retrospective cohort of 22 patients who underwent surgery for PD with dexmedetomidine sedation at a single institution from 2010 to 2014. A logistic regression analysis was performed to analyze possible confounding factors. Results: 14 cases of tremor reduction or suppression were recorded (cumulative incidence: 63.6%; 95% CI: 40.7-82.8). No association could be identified between loading dose, β-blocker use and preoperative total Unified Parkinson's Disease Rating Scale III, with tremor changes. The maintenance dose of dexmedetomidine was higher in patients who did not experience changes [median and range for patients with and without tremor alteration 0.75 (0.2-1.0) and 1.0 µg × kg-1 × h-1 (0.7-1.4), respectively; p = 0.021]. Conclusion: Dexmedetomidine provides adequate sedation during surgery for PD, but it might affect motor signs making intraoperative testing difficult or even impossible. Dosage appears not to be the determining factor in motor changes, whose cause remains unclear.
- 16 December 2015
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 93 (6) , 393-399
Factors Associated with Tremor Changes during Sedation with Dexmedetomidine in Parkinson's Disease Surgery
Introduction: Dexmedetomidine is an α2-agonist recently proposed as a potentially ideal drug for sedation during the surgical treatment of Parkinsonʼs disease (PD). This report documents the incidence of changes in motor symptoms (especially tremor) in PD patients sedated with dexmedetomidine for deep brain stimulation or ablation procedures. Methods: We reviewed a retrospective cohort of 22 patients who underwent surgery for PD with dexmedetomidine sedation at a single institution from 2010 to 2014. A logistic regression analysis was performed to analyze possible confounding factors. Results: 14 cases of tremor reduction or suppression were recorded (cumulative incidence: 63.6%; 95% CI: 40.7-82.8). No association could be identified between loading dose, β-blocker use and preoperative total Unified Parkinson's Disease Rating Scale III, with tremor changes. The maintenance dose of dexmedetomidine was higher in patients who did not experience changes [median and range for patients with and without tremor alteration 0.75 (0.2-1.0) and 1.0 µg × kg-1 × h-1 (0.7-1.4), respectively; p = 0.021]. Conclusion: Dexmedetomidine provides adequate sedation during surgery for PD, but it might affect motor signs making intraoperative testing difficult or even impossible. Dosage appears not to be the determining factor in motor changes, whose cause remains unclear.
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 27 (4) , 304-309
Safety Profile of 5-Aminolevulinic Acid as a Surgical Adjunct in Clinical Practice
5-Aminolevulinic acid (5-ALA) is used for brain tumor identification during surgery through fluorescence. Its use is linked to side effects such as photodermatosis, anemia, or plaquetopenia. Many institutions take very strict precautions to prevent them. Our hospital's protocol mandates avoidance of direct sunlight during the first 24 hours only. Retrospective cohort observational study of 207 consecutive patients who underwent 5-ALA-guided brain tumor resection between 2008 and 2013, and compared with a control group of 53 patients without 5-ALA. No skin reaction was reported. No difference was found in hemoglobin or platelet level comparisons at different points in time. There was no difference in trends within groups. Mean duration of surgery was longer in the 5-ALA group; the subgroup of patients undergoing their first surgery had a positive correlation with lower hemoglobin levels. In postoperative magnetic resonance imaging, patients in the 5-ALA group had a lower percentage of residual bleeding (19% of all patients; 17.9% in 5-ALA group and 22.7% in non-ALA [P=0.04]). Eight patients in the 5-ALA group required blood transfusion (3.9%), compared with 2 in the control group (3.8%). Four patients in the 5-ALA group required reintervention in the first 48 hours due to bleeding, although none had platelets <150,000/mL. Significant side effects appear to be uncommon. Blood count changes are likely multifactorial; surgical time may account for it partially, whereas 5-ALA role is not clear and may not be significant.
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 27 (4) , 304-309
Safety Profile of 5-Aminolevulinic Acid as a Surgical Adjunct in Clinical Practice
5-Aminolevulinic acid (5-ALA) is used for brain tumor identification during surgery through fluorescence. Its use is linked to side effects such as photodermatosis, anemia, or plaquetopenia. Many institutions take very strict precautions to prevent them. Our hospital's protocol mandates avoidance of direct sunlight during the first 24 hours only. Retrospective cohort observational study of 207 consecutive patients who underwent 5-ALA-guided brain tumor resection between 2008 and 2013, and compared with a control group of 53 patients without 5-ALA. No skin reaction was reported. No difference was found in hemoglobin or platelet level comparisons at different points in time. There was no difference in trends within groups. Mean duration of surgery was longer in the 5-ALA group; the subgroup of patients undergoing their first surgery had a positive correlation with lower hemoglobin levels. In postoperative magnetic resonance imaging, patients in the 5-ALA group had a lower percentage of residual bleeding (19% of all patients; 17.9% in 5-ALA group and 22.7% in non-ALA [P=0.04]). Eight patients in the 5-ALA group required blood transfusion (3.9%), compared with 2 in the control group (3.8%). Four patients in the 5-ALA group required reintervention in the first 48 hours due to bleeding, although none had platelets <150,000/mL. Significant side effects appear to be uncommon. Blood count changes are likely multifactorial; surgical time may account for it partially, whereas 5-ALA role is not clear and may not be significant.
- 1 December 2012
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 38 (12) , 2144-2153
Risks factors and regression model for risk calculation of anesthesiologic intervention in topical and intracameral cataract surgery
To determine risk factors for anesthesiologist intervention during routine cataract surgery performed with topical and intracameral anesthesia and establish a regression model to identify high-risk patients. Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain. Prospective case series. After cataract surgery at an ambulatory surgical center, anesthesia personnel completed a questionnaire to determine adverse medical events and risk factors related to anesthesiologist intervention. A Poisson regression model was used to calculate the interventional risks. Bootstrapping was performed for internal model validation. Of the 1010 cases, 50 (4.95%) required anesthesiologist intervention. Univariate analysis identified an association between anesthesiologist intervention and hypertension (P<.001), psychiatric history (P=.002), initial systolic blood pressure (P<.001), surgical duration (P=.001), and diabetes (P=.018). Scores were obtained using the following proposed regression model equation: (-8.68 + 0.33 × sex [men, 0; women, 1] + -0.02 × age [years] + 0.68 × hypertensive history [no, 0; yes, 1] + 1.18 × psychiatric background [no, 0; yes, 1] + 0.04 × initial systolic blood pressure [mm Hg]). The area under the receiver-operating curve was 0.803 (95% confidence interval [CI], 0.721-0.886). The area under the curve found in the validation method was 0.813 (95% CI, 0.727-0.887). Hypertension was the main risk factor for anesthesiologist intervention. The regression model discriminated between patients at lower and higher risk for intraoperative intervention for monitored anesthesia care. The probability of anesthesiologist intervention was 11.7 times higher when the model obtained a high score. No author has a financial or proprietary interest in any material or method mentioned.
- 1 December 2012
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 38 (12) , 2144-2153
Risks factors and regression model for risk calculation of anesthesiologic intervention in topical and intracameral cataract surgery
To determine risk factors for anesthesiologist intervention during routine cataract surgery performed with topical and intracameral anesthesia and establish a regression model to identify high-risk patients. Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain. Prospective case series. After cataract surgery at an ambulatory surgical center, anesthesia personnel completed a questionnaire to determine adverse medical events and risk factors related to anesthesiologist intervention. A Poisson regression model was used to calculate the interventional risks. Bootstrapping was performed for internal model validation. Of the 1010 cases, 50 (4.95%) required anesthesiologist intervention. Univariate analysis identified an association between anesthesiologist intervention and hypertension (P<.001), psychiatric history (P=.002), initial systolic blood pressure (P<.001), surgical duration (P=.001), and diabetes (P=.018). Scores were obtained using the following proposed regression model equation: (-8.68 + 0.33 × sex [men, 0; women, 1] + -0.02 × age [years] + 0.68 × hypertensive history [no, 0; yes, 1] + 1.18 × psychiatric background [no, 0; yes, 1] + 0.04 × initial systolic blood pressure [mm Hg]). The area under the receiver-operating curve was 0.803 (95% confidence interval [CI], 0.721-0.886). The area under the curve found in the validation method was 0.813 (95% CI, 0.727-0.887). Hypertension was the main risk factor for anesthesiologist intervention. The regression model discriminated between patients at lower and higher risk for intraoperative intervention for monitored anesthesia care. The probability of anesthesiologist intervention was 11.7 times higher when the model obtained a high score. No author has a financial or proprietary interest in any material or method mentioned.
- Open Access
- 1 January 2006
- Published by Springer Nature in Critical Care
- Vol. 10 (2) , 410
Erroneous measurement of haemodynamic parameters by PiCCO™ monitor in a critically ill patient with renal replacement therapy: a case report
- 1 January 2006
- Published by Springer Nature in Critical Care
- Vol. 10 (2) , 410
Open AccessErroneous measurement of haemodynamic parameters by PiCCO™ monitor in a critically ill patient with renal replacement therapy: a case report